Fusobacterium nucleatum as a Marker for Epithelial to Mesenchymal Transition in Colorectal Cancer
ISEF · 2022 Cellular and Molecular Biology Fourth Award
Overview
Colorectal cancer is the second most common cause of cancer death in the US, but it is curable and preventable if diagnosed early. Following the recent emphasis on the human microbiome's implications in cancer, a microbial diagnostic marker, Fusobacterium nucleatum, was investigated. CRC originates as a polyp that may undergo biochemical changes through the epithelial to mesenchymal transition (EMT), enabling it to metastasize. F. nucleatum, an abundant bacterium, is often found in gut and oral cavities and has been shown to promote colorectal carcinogenesis. F. nucleatum binds to the E-Cadherin epithelial cell surface adherence protein through adhesin fadA, which initiates EMT, inflammatory, and oncogenic responses. This project sought to assess F. nucleatum and EMT biomarkers in CRC. De-identified formalin fixed paraffin embedded tissue samples of different stages in CRC were immunostained for E-Cadherin and Vimentin as markers for epithelial and mesenchymal cells. Adhesin fadA was used as a marker for F. nucleatum. Normal tissue specimens were found to express E-Cadherin exclusively in mucosal epithelial cells, while mesenchymal cells in the stroma exclusively expressed Vimentin. Further, some precancerous and cancerous specimens showed Vimentin-positive foci within epithelial cells lacking E-Cadherin expression. Partial EMT was noted when E-Cadherin was downregulated in the tissue specimens. There was also presence of F. nucleatum secreted fadA, which plays a key role in transforming F. nucleatum from commensal to pathogenic. Therefore, its detection in the colon may aid in early CRC diagnosis and provide an opportunity for targeted intervention and personalized treatment plans to provide more predictive and detailed analysis of cancer initiation and progression.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2026
Spatial Analysis of Epithelial-to-Mesenchymal Transition Dynamics and Fusobacterium nucleatum Associations in Colorectal Cancer (Year 3)
ISEF · 2023
FadA-Secreting Fusobacterium nucleatum Promotes Inflammatory and Immunomodulatory Response in Colorectal Cancer (Year 2)
ISEF · 2019
Investigating the Role of Fusobacterium nucleatum in Esophageal Adenocarcinoma
ISEF · 2020
Analysis of Epithelial-Mesenchymal Transition Biomarkers, E-Cadherin and Vimentin, in Colorectal Cancer
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair